DaVita Inc. Schedules 4th Quarter 2024 Investor Conference Call
Werte in diesem Artikel
DENVER, Jan. 30, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Thursday, February 13, 2025, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.
This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows:
Thursday, February 13, 2025
Starting at 5:00 p.m. EST
Webcast can be accessed using this link
Dial in number: 877-918-6630
International dial in: 517-308-9042
When calling in, please provide the operator the password "Earnings" and provide your name and company affiliation. Investors unable to listen to the conference call will be able to access a replay via our website at investors.davita.com. There will be no telephone replay.
About DaVita Inc.
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of September 30, 2024, DaVita served approximately 265,400 patients at 3,113 outpatient dialysis centers, of which 2,660 centers were located in the United States and 453 centers were located in 13 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.
Contact Information
Investors:
IR@davita.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/davita-inc-schedules-4th-quarter-2024-investor-conference-call-302364622.html
SOURCE DaVita
Ausgewählte Hebelprodukte auf DaVita
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf DaVita
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu DaVita Inc Registered Shs
Analysen zu DaVita Inc Registered Shs
Datum | Rating | Analyst | |
---|---|---|---|
03.01.2019 | DaVita HealthCare Partners Buy | Deutsche Bank AG | |
14.12.2018 | DaVita HealthCare Partners Overweight | Barclays Capital | |
12.12.2017 | DaVita HealthCare Partners Outperform | Robert W. Baird & Co. Incorporated | |
08.11.2017 | DaVita HealthCare Partners Sector Perform | RBC Capital Markets | |
13.12.2016 | DaVita HealthCare Partners Neutral | Robert W. Baird & Co. Incorporated |
Datum | Rating | Analyst | |
---|---|---|---|
03.01.2019 | DaVita HealthCare Partners Buy | Deutsche Bank AG | |
14.12.2018 | DaVita HealthCare Partners Overweight | Barclays Capital | |
12.12.2017 | DaVita HealthCare Partners Outperform | Robert W. Baird & Co. Incorporated | |
27.04.2015 | DaVita HealthCare Partners Outperform | Robert W. Baird & Co. Incorporated | |
18.10.2011 | DaVita outperform | Robert W. Baird & Co. Incorporated |
Datum | Rating | Analyst | |
---|---|---|---|
08.11.2017 | DaVita HealthCare Partners Sector Perform | RBC Capital Markets | |
13.12.2016 | DaVita HealthCare Partners Neutral | Robert W. Baird & Co. Incorporated | |
04.11.2015 | DaVita HealthCare Partners Sector Perform | RBC Capital Markets | |
06.08.2015 | DaVita HealthCare Partners Sector Perform | RBC Capital Markets | |
13.03.2015 | DaVita HealthCare Partners Hold | Deutsche Bank AG |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für DaVita Inc Registered Shs nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen